Search Results 341-350 of 17532 for vitiligo

  1. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    Vitiligo or resolved childhood asthma/atopy;; Intermittent use of bronchodilators or local steroid injections;; Hypothyroidism stable on hormone replacement ...

  2. A Study of AP160-Complex in Advanced Solid Tumors - Mayo Clinic

    Vitiligo or resolved childhood asthma/atopy;; Intermittent use of bronchodilators or local steroid injections;; Non-immunosuppressive maintenance treatments ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Vulvar skin disorder, Breast skin change, Rosacea, Pigmentation ...

  4. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  5. A Study of RP2 with Nivolumab compared to Ipilimumab with Nivolumab with Metastatic Uveal Melanoma - Mayo Clinic

    ... vitiligo, psoriasis, or alopecia) not requiring systemic treatment, or prior autoimmune conditions not expected to recur are eligible. History of ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Vulvar skin disorder, Breast skin change, Rosacea, Pigmentation ...

  7. A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma - Mayo Clinic

    ... vitiligo, or asthma not requiring systemic steroids. Known HIV or chronic Hepatitis B or C infection. Known hypersensitivity to any temozolomide component ...

  8. Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer - Mayo Clinic

    Patients with vitiligo or resolved childhood asthma/atopy would be an exception to this rule. Patients that require intermittent use of bronchodilators or ...

  9. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    Subjects with type I diabetes mellitus, hypothyroidism only requiring hormone replacement, skin disorders (such as vitiligo, psoriasis, or alopecia) not ...

  10. Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer - Mayo Clinic

    Patients with vitiligo, endocrine deficiencies including type I diabetes mellitus, thyroiditis managed with replacement hormones including physiologic ...